12 | Cancer Commissioning Strategy Framework Cancer Commissioning Strategy Framework | 13 Strategic Planning Procuring Services Monitoring and Evaluation Patients/ Public 2.1 Developing and Designing Services 2.2 Cancer Service Implementation Planning 2.3 Planning Capacity and Managing Demand 1.1 Assessing Needs 1.2 Reviewing Service Provisions 1.3 Deciding Priorities 3.2 Supporting Patient Choice 3.1 Managing Performance 3.3 Seeking Public and Patient Views Cancer Service Procurement and Development (January - April) Cancer Service Strategic Planning (September - December) Cancer Services Monitoring and Evaluation (May - August) 1.1 Assessing needs a. Utilise the Fragile Services Framework to assess and identify gaps in cancer services and resources. b. Identify key challenges and vulnerabilities within cancer services. 1.2 Reviewing service provisions a. Use the Expert Reference Group [ERG] Fragile Services Cancer Checklist as a guide for evaluation. b. Conduct annual review of the current Cancer Commissioning Strategy, ensuring alignment with updated national policies and service needs. 1.3 Deciding priorities a. Apply the Cancer Prioritisation Framework to identify top priorities based on national and regional cancer outcomes. b. Ensure alignment with National Planning Guidance (ICB and Cancer Alliance documents). c. Conduct a Cancer Leads Workshop to gather input and feedback from key NCL stakeholders. d. Set out Commissioning Pipeline (Commissioning Intentions) for key stakeholders. NCL Cancer Commissioning Cycle 2.1 Developing and Designing services a. Develop comprehensive Cancer Service Specifications (including operational and clinical guidelines, as required) that detail the requirements for delivering quality cancer care. 2.2 Cancer Service Implementation Planning a. Collaborate with service providers to optimise the structure and capacity of cancer care services, ensuring efficient use of resources. b. Review the Trust data Quality Improvement Plan. 2.3 Planning capacity and managing demand a. Cancer Alliance Challenge and Confirm Meeting to confirm available capacity and manage demand, ensuring alignment with anticipated patient flows and treatment needs. 3.1 Managing performance a. Monitor performance metrics across cancer services, including patient outcomes, treatment wait times, and adherence to guidelines. 3.2 Supporting patient choice a. Ensure patient choice is actively supported, with clear pathways for selecting preferred treatment options and locations. 3.3 Seeking public and patient views a. Engage with patients and the public through surveys, focus groups, and consultations to gather insights and feedback on service performance and areas for improvement. The NCL Cancer Commissioning Cycle is a framework that outlines the iterative process of commissioning, encompassing strategic planning, procuring services and monitoring outcomes. It ensures that services are continuously evaluated and adapted to meet evolving needs. The cycle integrates input from patients and the public at every stage, ensuring that commissioned services reflect their needs and preferences.
RkJQdWJsaXNoZXIy NTI5NzM=